Healthcare Industry News: DFINE
News Release - June 3, 2010
DFine Appoints Jim Mazzarella to the Position of Vice President of SalesSAN JOSE, Calif.--(HSMN NewsFeed)--DFINE, Inc., a developer of minimally invasive solutions for treating vertebral pathologies, announced today the appointment of James M. (Jim) Mazzarella to the position of Vice President of Sales. Jim brings to DFINE over 25 years of high level sales and marketing experience in the medical device industry. He began his career at Johnson & Johnson, where he assumed increasingly greater levels of responsibility in sales management and marketing during his 20 years with the company, eventually directing the launch of the now market-leading STERRAD® low temperature sterilization system at Advanced Sterilization Products, a division of Ethicon. Jim also held senior leadership roles at Medpool.com and TSO3, Inc.
“Jim is a consummate sales management professional, and his successful track record in building high performing sales organizations will help DFINE accelerate the expansion of our commercialization efforts here in the US,” said Kevin Mosher, Chief Executive Officer of DFINE, Inc. “Particularly noteworthy is Jim’s depth of experience in introducing new medical devices over the course of his career, which makes him an ideal candidate for our organization. I am very pleased to have him join our senior management team.”
Prior to DFINE, Jim worked for several start-up companies in market development and sales leadership roles. His areas of expertise, particularly as it pertains to start up companies include building sales organizations, new product launches, pricing strategy, corporate account contracting, and key account management. Jim holds a bachelor’s degree in psychology from Moravian College and has attended professional development programs at the Wharton Business School and the Kellogg School of Management at Northwestern University.
DFINE, Inc., a privately held medical device company based in San Jose, Calif., is dedicated to improving patient quality of life through the development of innovative, minimally invasive therapeutic devices used to treat pathologies of the vertebrae. RF Kyphoplasty with the StabiliT® Vertebral Augmentation System is DFINE’s flagship product line providing physicians greater control in the treatment of vertebral compression fractures through site and size specific cavity creation and an ultra high viscosity bone cement over an extended working time using a remotely controlled delivery system to stabilize the fracture, relieve pain and improve patient quality of life. For more information, visit www.DFINEinc.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.